Literature DB >> 12493780

Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide.

George M Bahr1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12493780     DOI： 10.1093/jac/dkg063

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

Review 1.  Modulating immunity as a therapy for bacterial infections.

Authors:  Robert E W Hancock; Anastasia Nijnik; Dana J Philpott
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

Review 2.  Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.

Authors:  Charles Maisonneuve; Sylvie Bertholet; Dana J Philpott; Ennio De Gregorio
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

3.  Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients.

Authors:  Francesca Sabbatini; Alessandra Bandera; Giulio Ferrario; Daria Trabattoni; Giulia Marchetti; Fabio Franzetti; Mario Clerici; Andrea Gori
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

4.  Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cells.

Authors:  G M Bahr; E C A Darcissac; Y Mouton
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

5.  Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection.

Authors:  François Coulombe; Stéphanie Fiola; Shizuo Akira; Yvon Cormier; Jean Gosselin
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

6.  Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs.

Authors:  Sandeep D Kale; Neha Dikshit; Pankaj Kumar; Vanniarajan Balamuralidhar; Hanif Javanmard Khameneh; Najib Bin Abdul Malik; Tse Hsien Koh; Gladys Gek Yen Tan; Thuan Tong Tan; Alessandra Mortellaro; Bindu Sukumaran
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

Review 7.  Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications.

Authors:  Chung-Nga Ko; Shaohong Zang; Yingtang Zhou; Zhangfeng Zhong; Chao Yang
Journal:  J Nanobiotechnology       Date:  2022-08-19       Impact factor: 9.429

8.  Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine.

Authors:  Erin M Jackson; Melissa M Herbst-Kralovetz
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.